COMPANY INSIGHT

Sponsored by Pharma Support Services

Pharma Support Services Ltd  - your regulatory and pharmaco vigilance provider in Eastern Europe

Achieving compliance with local requirements can be a tough deal and an unexpected challenge sometimes

Hence you need a partner you can trust

Given the diversity of the Eastern European region and the fact that the languages spoken are very different from one another (as both Cyrillic and Latin alphabets are used in the region dependent on the country) launching your products can be a challenge. It needs to be matched with a local expertise in regulatory affairs, pharmacovigilance and pricing - all of which are essentials for speedy access to Eastern European markets. Whether you are only exploring possibilities to expand or already have presence in Eastern Europe we can adapt our services to be of help to your business.

As a first prerequisite we ensure you receive a well-grounded legal advice and country-specific background. Based in Sofia, Bulgaria and having reliable partners all over Eastern Europe, we can find the right partner for you should you be looking for a GMP, GDP compliant warehouse or support with medical devices and medicinal products registration and their pricing and reimbursement possibilities. As the healthcare systems in many of the countries in the region are based on the so-called „external reference pricing system“ we can provide guidance on which countries are included in the reference basket and what strategy can be adopted to secure your product on the market.

we can find the right partner for you should you be looking for a GMP

Worried about Brexit outcome?

Further down the line of establishing in your business in Eastern Europe we are happy to support you with transfer of marketing authorisations, finalization of national phases of your DCP/MRP applications as well as start a national authorisation procedure for your product, should you be interested in one market only. We have a broad expertise in registration and communication of all necessary requirements so that you can focus on marketing your products while we do the rest.

In addition to local pharmacovigilance point of contact as well as literature screening of non-indexed journals and publications we perform follow-up assessment of relevant articles/scientific extracts. Medical review of cases published in literature can help you identify important signals concerning the safety profile of your products. And a lot of locally issued journals are not indexed by Embase and Medline, so we can provide further assistance with these issues.

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI